| # | Drug | Count |
|---|---|---|
| 0 | EVEROLIMUS | 44 |
| 1 | ENZALUTAMIDE | 31 |
| 2 | OCTREOTIDE ACETATE | 30 |
| 3 | CETUXIMAB | 29 |
| 4 | NILOTINIB | 26 |
| 5 | LENALIDOMIDE | 25 |
| 6 | LEUPROLIDE ACETATE | 23 |
| 7 | PREDNISONE | 22 |
| 8 | DEXAMETHASONE | 21 |
| 9 | DEXAMETHASONE 1.5 MG | 21 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | METYROSINE | 1 | 0.0123 |
| 1 | MIGALASTAT HYDROCHLORIDE | 3 | 0.0054 |
| 2 | ROLAPITANT | 1 | 0.0019 |
| 3 | AIRBORNE | 1 | 0.0015 |
| 4 | ZOLBETUXIMAB | 2 | 0.0013 |
| 5 | CALASPARGASE PEGOL | 1 | 0.0012 |
| 6 | DATOPOTAMAB DERUXTECAN | 1 | 0.0012 |
| 7 | SACITUZUMAB GOVITECAN | 5 | 0.0010 |
| 8 | MEGESTROL ACETATE | 4 | 0.0010 |
| 9 | NELARABINE | 1 | 0.0010 |
| # | Drug class | Count |
|---|---|---|
| 0 | Kinase Inhibitor [EPC] | 84 |
| 1 | Corticosteroid [EPC] | 47 |
| 2 | mTOR Inhibitor Immunosuppressant [EPC] | 44 |
| 3 | Androgen Receptor Inhibitor [EPC] | 32 |
| 4 | Thalidomide Analog [EPC] | 32 |
| 5 | Epidermal Growth Factor Receptor Antagonist [EPC] | 29 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 29 |
| 7 | Nucleoside Metabolic Inhibitor [EPC] | 29 |
| 8 | Platinum-based Drug [EPC] | 27 |
| 9 | Opioid Agonist [EPC] | 23 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Catecholamine Synthesis Inhibitor [EPC] | 1 | 0.0123 |
| 1 | Non-Standardized House Dust Allergenic Extract [EPC] | 1 | 0.0013 |
| 2 | Claudin 18.2-directed Cytolytic Antibody [EPC] | 2 | 0.0013 |
| 3 | Standardized Animal Hair Allergenic Extract [EPC] | 1 | 0.0012 |
| 4 | Adrenocorticotropic Hormone [EPC] | 1 | 0.0011 |
| 5 | Adrenal Steroid Synthesis Inhibitor [EPC] | 1 | 0.0010 |
| 6 | Actinomycin [EPC] | 2 | 0.0009 |
| 7 | Epidermal Growth Factor Receptor Antagonist [EPC] | 29 | 0.0006 |
| 8 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 3 | 0.0005 |
| 9 | Androgen Receptor Inhibitor [EPC] | 32 | 0.0004 |